Corneal perforation associated with topically applied gatifloxacin.
OBJECTIVE
To document the development of corneal perforation after using gatifloxacin to treat inflamed pterygium.


METHODS
A 30-year-old man developed corneal perforation after using gatifloxacin to treat inflamed pterygium.


RESULTS
After treatment with gatifloxacin was stopped, the perforation was managed by applying cyanoacrylate glue, followed by pterygium excision.


CONCLUSIONS
If used in the management of inflamed pterygium, gatifloxacin may predispose patients to corneal perforation.
Al-Amri
Abdulrahman Mohammed
AM
Department of Ophthalmology, College of Medicine, King Khalid University, Abha, Saudi Arabia. amaamri@hotmail.com
D000287:Administration, Topical; D000328:Adult; D000890:Anti-Infective Agents / Q000009:adverse effects*; D003315:Cornea / Q000187:drug effects*; D003316:Corneal Diseases / Q000139:chemically induced*; D024841:Fluoroquinolones / Q000009:adverse effects*; D000077734:Gatifloxacin; D006801:Humans; D008297:Male; D011625:Pterygium / Q000188:drug therapy; D012422:Rupture, Spontaneous
D000890:Anti-Infective Agents; D024841:Fluoroquinolones; D000077734:Gatifloxacin